US$ 27.40
nobel prize glp 1 GLP-1-based therapy for obesity GLP-1 | Summary
Description
Background: Type 2 diabetes mellitus (T2D) is associated with an increased fracture risk

Earlier this year, Blue Cross Blue Shield said five GLP-1 drugs now account for nearly 20% of its pharmacy spend.

The heatmap below illustrates how side effects differ across GLP-1 drugs, offering a snapshot of how people experience their GLP-1 medication in everyday life

The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157

Congratulations to Joel Habener, Lotte Bjerre Knudsen, and Svetlana Mojsov, 2024 #LaskerAward winners
